---
title: "300122.SZ (300122.SZ) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/300122.SZ/news.md"
symbol: "300122.SZ"
name: "300122.SZ"
parent: "https://longbridge.com/en/quote/300122.SZ.md"
datetime: "2026-05-21T12:14:34.574Z"
locales:
  - [en](https://longbridge.com/en/quote/300122.SZ/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/300122.SZ/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/300122.SZ/news.md)
---

# 300122.SZ (300122.SZ) — Related News

### [ZHIFEI-BIOL's six-year "old accounts" difficult to conceal tricks, hundred billion giant losses drag down former "vaccine king"?](https://longbridge.com/en/news/286711080.md)
*2026-05-18T03:38:36.000Z*
> ZHIFEI-BIOL is under supervision by the Shenzhen Stock Exchange due to accounting errors, with the chairman and executiv

### ["The King of Vaccines" lost 14.7 billion and was angrily confronted by shareholders. How does the "richest person in Chongqing" support ZHIFEI-BIOL?](https://longbridge.com/en/news/286071945.md)
*2026-05-12T09:14:38.000Z*
> ZHIFEI-BIOL faced questioning from investors during the performance briefing, as investors have suffered losses exceedin

### [Vaccine sector stocks have collectively surged, with some funds entering during the low period to "buy the dip."](https://longbridge.com/en/news/285936446.md)
*2026-05-11T11:43:16.000Z*
> On May 11th, the vaccine sector saw a general rise in stock prices, with WALVAX hitting the limit up, and companies such

### [1 million investment only left a few thousand! ZHIFEI-BIOL was criticized at the earnings meeting, with a huge loss of 14.7 billion in 2025](https://longbridge.com/en/news/285841643.md)
*2026-05-10T12:05:37.000Z*
> At the 2025 performance briefing, ZHIFEI-BIOL faced questions from investors, claiming that investors had lost over 95%.

### [Investment "1 million left with only a few thousand," "King of Vaccines" ZHIFEI-BIOL faced questioning at the performance meeting](https://longbridge.com/en/news/285803937.md)
*2026-05-09T08:09:08.000Z*
> ZHIFEI-BIOL faced skepticism from investors during the earnings conference, as its stock price continued to be under pre

### [](https://longbridge.com/en/news/285700747.md)
*2026-05-08T09:53:15.000Z*
> ZHIFEI-BIOL received a regulatory letter from the Shenzhen Stock Exchange

### [Two billionaires face their "darkest hour" together](https://longbridge.com/en/news/285493929.md)
*2026-05-07T06:06:35.000Z*
> Two HPV vaccine companies, Wantai Biological and ZHIFEI-BIOL, are facing a severe financial crisis. Wantai Biological's 

### [70% of GEM companies made a profit last year: CATL firmly holds the top position in the GEM, while ZHIFEI-BIOL suffered record losses](https://longbridge.com/en/news/285184512.md)
*2026-05-05T10:09:38.000Z*
> As of the end of April, 1,397 companies listed on the ChiNext board announced their performance reports for the year 202

### [ZHIFEI-BIOL lost 40 million daily, what happened?](https://longbridge.com/en/news/284961304.md)
*2026-05-02T08:25:39.000Z*
> ZHIFEI-BIOL faced an annual loss of 14.7 billion yuan in 2025, becoming the largest loss in the history of the A-share p

### [Financial Report Interpretation | 5 Vaccine Companies Lost 16.1 Billion Yuan Last Year, Over 10 Billion HPV Vaccines Left in Hand](https://longbridge.com/en/news/284740772.md)
*2026-04-30T09:53:20.000Z*
> The vaccine industry is facing losses, with 14 A-share vaccine companies projected to have a total net loss of 13.632 bi